In an age of increasingly bespoke healthcare, Elizabeth Philp has become a leading voice of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a drive to make custom medications more accessible, disrupting the conventional one-size-fits-all approach